Andlauer Healthcare Group Inc.
ANDHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $650 | $648 | $648 | $440 |
| % Growth | 0.4% | -0.1% | 47.3% | – |
| Cost of Goods Sold | $503 | $500 | $490 | $329 |
| Gross Profit | $147 | $147 | $159 | $111 |
| % Margin | 22.6% | 22.8% | 24.5% | 25.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $53 | $51 | $49 | $37 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $53 | $51 | $49 | $37 |
| Operating Income | $94 | $96 | $110 | $74 |
| % Margin | 14.4% | 14.8% | 17% | 16.7% |
| Other Income/Exp. Net | -$6 | -$5 | -$7 | $35 |
| Pre-Tax Income | $88 | $91 | $104 | $108 |
| Tax Expense | $24 | $24 | $27 | $18 |
| Net Income | $64 | $66 | $76 | $90 |
| % Margin | 9.9% | 10.2% | 11.8% | 20.4% |
| EPS | 1.6 | 1.55 | 1.82 | 2.3 |
| % Growth | 3.2% | -14.8% | -20.9% | – |
| EPS Diluted | 1.58 | 1.55 | 1.79 | 2.25 |
| Weighted Avg Shares Out | 39 | 43 | 42 | 39 |
| Weighted Avg Shares Out Dil | 40 | 43 | 43 | 40 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $3 | $1 | $0 |
| Interest Expense | $8 | $8 | $7 | $6 |
| Depreciation & Amortization | $71 | $38 | $64 | $43 |
| EBITDA | $167 | $134 | $175 | $157 |
| % Margin | 25.6% | 20.6% | 27% | 35.8% |